PFIZER HAS ENDED COVID 19 VACCINE TRIAL WITH 95 PERCENT SUCCESS RATE.
It was reported that Pfizer has ended COVID-19 vaccine trial, with the success rate of 95% and two months of safety data. The drug maker said there were 170 cases of COVID-19 in its trial of more than 43,000 volunteers and only eight people with the disease had been given the shot rather than a […]
PFIZER HAS ENDED COVID 19 VACCINE TRIAL WITH 95 PERCENT SUCCESS RATE. Read More »
